Onconetix, Inc. (ONCO)
0.656
+0.01
(+0.85%)
USD |
NASDAQ |
Aug 24, 16:00
0.6575
0.00 (0.00%)
After-Hours: 07:46
Onconetix Profit Margin (Quarterly) : -16.77K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.77K% |
| March 31, 2026 | -19.60K% |
| December 31, 2025 | |
| September 30, 2025 | -2.89K% |
| June 30, 2025 | -2.23K% |
| March 31, 2025 | -8.41K% |
| Date | Value |
|---|---|
| December 31, 2024 | -4.13K% |
| September 30, 2024 | -940.6% |
| June 30, 2024 | -2.03K% |
| March 31, 2024 | -1.59K% |
| December 31, 2023 | -38.21K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Aprea Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.5% |
| Return on Assets | -53.67% |
| Return on Invested Capital | -84.74% |
| Gross Profit Margin (Quarterly) | 25.15% |
| Operating Margin (Quarterly) | -13.13K% |
| Return on Net Operating Assets | -65.46% |